Stem Cell Approaches in Neurology and Psychiatry Published October 15, 2008
An industry insider report on innovative research and development in stem cell technology for the central nervous system
- Analyzes the scientific approaches and challenges to utilizing stem cells in the CNS - Discusses trends and drivers including funding and regulatory issues - Reveals promising treatment indications and pipelines - Details cell therapies for Parkinson's, SCI, stroke, Alzheimer's, ALS, MS, retina and more - Examines business models leveraging the promise of stem cells - Sheds light on investment opportunities and risks - Provides in-depth profiles of trendsetters and trailblazers
Table of Contents Over 125 Companies Included
|
27 Trendsetters for 2009:
- Aastrom Biosciences
- Advanced Cell Technology - ArunA Biomedical - Athersys - Beike Biotechnology Company
- BrainCells, Inc.
- BrainStorm Cell Therapeutics
- California Stem Cell
- Cell Cure Neurosciences - CellMed AG - Geron Corporation - International Stem Cell Corporation
- NeuralStem
- NeuroGeneration - NeuroNascent - NeuroNova AB
- Neuronyx - NsGene A/S - Pfizer Regenerative Medicine - Q Therapeutics - ReNeuron Group - RhinoCyte
- Stem Cell Sciences
- Stem Cell Therapeutics
- StemCell Technologies
- StemCells, Inc.
- Theradigm, Inc.
|
|
|